• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South America Clinical Trials Market

    ID: MRFR/HS/48509-HCR
    200 Pages
    Garvit Vyas
    September 2025

    South America Clinical Trials Market Research Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Diseases, Endocrinology), By End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South America Clinical Trials Market Research Report — Global Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    South America Clinical Trials Market Summary

    The South America Clinical Trials market is projected to grow from 5.5 USD Billion in 2024 to 9 USD Billion by 2035.

    Key Market Trends & Highlights

    South America Clinical Trials Key Trends and Highlights

    • The market is expected to expand at a CAGR of 4.58 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 9 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 5.5 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of innovative clinical trial methodologies due to increasing demand for efficient drug development is a major market driver.

    Market Size & Forecast

    2024 Market Size 5.5 (USD Billion)
    2035 Market Size 9 (USD Billion)
    CAGR (2025-2035) 4.58%

    Major Players

    Covance, Medpace, ClinTec International, PRA Health Sciences, Celerion, WuXi AppTec, Charles River Laboratories, Worldwide Clinical Trials, Syneos Health, PAREXEL International, CROMSOURCE, ICON plc, QuintilesIMS, KCR

    South America Clinical Trials Market Trends

    In South America, the market for clinical trial services seems to be gaining momentum driven by some primary market factors. In South America, there is an increase in the volume of chronic diseases which, together with the demand for new drugs, compels deep study. South American countries are well known for doing promotional activities for the regulatory policies, which are now supporting the streamlining of the approval processes necessary to conduct clinical trials in these countries and thus making research friendly environment for the companies.

    Also, the increased investments in healthcare systems in these countries greatly improve the clinical trial landscape because they offer the required infrastructure and trained specialized personnel. Savvy clinical trial managers can also find South America as an untapped opportunity in the region's lack of medical research, especially in dealing with prevalent neglected tropical diseases and certain genetic disorders. The region has a rich clinical genetic repository that can be accessed for better results in studies.

    The region can also benefit from enhanced drug invention processes through increased collaboration of local research agencies with global pharmaceutical companies. Recently, owing to technological developments and the need for customer-satisfaction, there has been a movement towards remote clinical trial centers in South America. Solutions in digital health, including telehealth and mobile health services, are now fundamental components in the conduct of clinical trials as they increase patient participation and data collection opportunities.

    After the pandemic, these innovations have increased significantly, indicating that the future of clinical trials in South America will be more integrated and virtual. This change is supported by local policies that are changing their frameworks to facilitate the new approaches and encouraging clinical research in the area.

    South America Clinical Trials Market Drivers

    Market Segment Insights

    Get more detailed insights about South America Clinical Trials Market Research Report — Global Forecast till 2035

    Regional Insights

    The South America Clinical Trials Market is experiencing notable activity across various regions, particularly in Brazil, Mexico, Argentina, and the Rest of South America. Brazil holds a significant position due to its large population and established clinical research infrastructure, making it a preferred choice for many sponsors. Mexico follows closely as a hub for clinical trials, supported by its regulatory environment that encourages Research and Development (R&D) activities and cost-effective operations. Argentina presents opportunities driven by its highly skilled workforce and robust scientific community, which enhances the quality of clinical research.

    Meanwhile, the Rest of South America showcases a growing interest in clinical trials, with emerging markets steadily increasing their participation. The combination of supportive governmental policies, a diverse patient pool, and competitive costs contributes to the growing prominence of these regions in the South America Clinical Trials Market. The market is poised for steady growth as these countries continue to invest in healthcare infrastructure and foster innovation in the clinical research sector. The collaboration among stakeholders in these regions is essential for enhancing study quality and patient recruitment, thereby driving advancements in medical science and treatment options across South America.

    Source Primary Research, Secondary Research, MRFR Database and Analyst Review

    Key Players and Competitive Insights

    The South America Clinical Trials Market is experiencing dynamic growth driven by a combination of increasing investments in healthcare infrastructure, the rise of outsourcing by pharmaceutical companies, and a growing focus on innovative therapies. The competitive landscape is characterized by numerous players aiming to establish their presence in this evolving market. Companies are leveraging strategic partnerships, technological advancements, and a deeper understanding of local regulatory frameworks to enhance their offerings. The market is marked by both multinational corporations and emerging local firms, which strive to capitalize on the diverse patient populations and favorable regulatory environments that South America offers.

    This competitive arena is dynamic, presenting a range of opportunities for stakeholders to optimize the clinical trial processes and deliver results faster and more efficiently. Covance has a strong foothold in the South America Clinical Trials Market, leveraging its extensive experience in conducting clinical trials across various therapeutic areas. With a focus on providing comprehensive solutions, Covance brings significant operational efficiency through its robust infrastructure and experienced workforce. The company's strength lies in its ability to tailor services specific to regional needs, ensuring compliance with local regulatory requirements while maintaining high standards of quality.

    Covance's comprehensive approach to clinical development, combined with its insights into patient engagement and site management, positions it favorably against local competitors. The company has strategically established partnerships with local healthcare providers and regulatory bodies to facilitate smoother trial processes, enhancing its reputation and market presence. Medpace is another prominent player in the South America Clinical Trials Market, known for its specialized services in clinical development across various therapeutic fields, including oncology, cardiovascular, and infectious diseases. Medpace distinguishes itself by offering a full-service approach that encompasses the entire clinical trial lifecycle, from study design through to regulatory submission.

    Its strengths lay in its deep therapeutic expertise, strong project management capabilities, and innovative technology solutions that streamline trial processes. Additionally, Medpace has been actively involved in strategic mergers and acquisitions to enhance its geographic reach and service capabilities within South America. These strategic moves have allowed the company to expand its network of sites and enhance its clinical trial services, ensuring it remains competitive in an evolving market. The combination of established relationships with local healthcare systems and an understanding of regional regulations further positions Medpace as a strong contender in the South American clinical trials landscape.

    Key Companies in the South America Clinical Trials Market market include

    Industry Developments

    The South America Clinical Trials Market has witnessed significant developments recently, particularly in Brazil and Argentina, which are now emerging as key players in the global clinical research landscape. In September 2023, Covance announced an expansion of their clinical trial capabilities in Brazil, aiming to streamline patient recruitment processes and improve operational efficiencies in the region. Medpace followed suit by opening a new research facility in So Paulo in August 2023, targeting the growing demand for innovative therapies in the region.

    Furthermore, PR Health Sciences has been in the spotlight due to its partnerships with local universities to foster Research and Development efforts.

    Notably, in July 2023, Celerion was involved in a strategic acquisition, enhancing its presence in the South American market. This region's market valuation has been on the rise, driven by increasing investment in healthcare infrastructure and a higher prevalence of chronic diseases necessitating advanced clinical trials. In the last couple of years, significant strides have been made to adopt regulatory frameworks, facilitating quicker approval processes for clinical trials that further accelerate growth in this vital sector.

    Market Segmentation

    Clinical Trials Market Phase Outlook

    • Phase I
    • Phase II
    • Phase III
    • Phase IV

    Clinical Trials Market End Use Outlook

    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations

    Clinical Trials Market Regional Outlook

    • Brazil
    • Mexico
    • Argentina
    • Rest of South America

    Clinical Trials Market Study Design Outlook

    • Interventional
    • Observational
    • Expanded Access

    Clinical Trials Market Therapeutic Area Outlook

    • Oncology
    • Cardiology
    • Neurology
    • Infectious Diseases
    • Endocrinology

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 5.05(USD Billion)
    MARKET SIZE 2024 5.5(USD Billion)
    MARKET SIZE 2035 9.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.579% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Covance, Medpace, ClinTec International, PRA Health Sciences, Celerion, WuXi AppTec, Charles River Laboratories, Worldwide Clinical Trials, Syneos Health, PAREXEL International, CROMSOURCE, ICON plc, QuintilesIMS, KCR
    SEGMENTS COVERED Phase, Study Design, Therapeutic Area, End Use, Regional
    KEY MARKET OPPORTUNITIES Growing patient recruitment diversity, Increased government support initiatives, Expanding biotechnology sector investments, Rising demand for innovative therapies, Enhanced data analytics adoption.
    KEY MARKET DYNAMICS Regulatory environment changes, Growing population needs, Increasing healthcare investments, Rising prevalence of chronic diseases, Expanding pharmaceutical sector
    COUNTRIES COVERED Brazil, Mexico, Argentina, Rest of South America

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the expected market size of the South America Clinical Trials Market in 2024?

    The South America Clinical Trials Market is expected to be valued at 5.5 USD Billion in 2024.

    What will the market size of the South America Clinical Trials Market be by 2035?

    By 2035, the South America Clinical Trials Market is projected to reach 9.0 USD Billion.

    What is the expected CAGR for the South America Clinical Trials Market from 2025 to 2035?

    The South America Clinical Trials Market is expected to grow at a CAGR of 4.579% from 2025 to 2035.

    Which country holds the largest market share in the South America Clinical Trials Market?

    Brazil is expected to hold the largest market share, valued at 2.1 USD Billion in 2024.

    What is the projected market growth for Brazil in the Clinical Trials Market by 2035?

    The market for Brazil is projected to grow to 3.4 USD Billion by 2035.

    Who are the key players in the South America Clinical Trials Market?

    Key players in the market include Covance, Medpace, Principia and PAREXEL International among others.

    What is the expected market value for Phase I Clinical Trials in 2024?

    The market value for Phase I Clinical Trials is anticipated to be 1.26 USD Billion in 2024.

    How much is the market for Phase III Clinical Trials expected to be in 2035?

    The market for Phase III Clinical Trials is expected to reach 2.36 USD Billion by 2035.

    Which region besides Brazil is significant in the South America Clinical Trials Market?

    Mexico is another significant market, valued at 1.5 USD Billion in 2024.

    What challenges could impact the growth of the South America Clinical Trials Market?

    Challenges such as regulatory hurdles and competition among CROs could impact market growth.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. South America Clinical Trials Market, BY Phase (USD Billion)
    45. Phase I
    46. Phase II
    47. Phase III
    48. Phase IV
    49. South America Clinical Trials Market, BY Study Design (USD Billion)
    50. Interventional
    51. Observational
    52. Expanded Access
    53. South America Clinical Trials Market, BY Therapeutic Area (USD Billion)
    54. Oncology
    55. Cardiology
    56. Neurology
    57. Infectious Diseases
    58. Endocrinology
    59. South America Clinical Trials Market, BY End Use (USD Billion)
    60. Pharmaceutical Companies
    61. Biotechnology Companies
    62. Contract Research Organizations
    63. South America Clinical Trials Market, BY Regional (USD Billion)
    64. Brazil
    65. Mexico
    66. Argentina
    67. Rest of South America
    68. Competitive Landscape
    69. Overview
    70. Competitive Analysis
    71. Market share Analysis
    72. Major Growth Strategy in the Clinical Trials Market
    73. Competitive Benchmarking
    74. Leading Players in Terms of Number of Developments in the Clinical Trials Market
    75. Key developments and growth strategies
    76. New Product Launch/Service Deployment
    77. Merger & Acquisitions
    78. Joint Ventures
    79. Major Players Financial Matrix
    80. Sales and Operating Income
    81. Major Players R&D Expenditure. 2023
    82. Company Profiles
    83. Covance
    84. Financial Overview
    85. Products Offered
    86. Key Developments
    87. SWOT Analysis
    88. Key Strategies
    89. Medpace
    90. Financial Overview
    91. Products Offered
    92. Key Developments
    93. SWOT Analysis
    94. Key Strategies
    95. ClinTec International
    96. Financial Overview
    97. Products Offered
    98. Key Developments
    99. SWOT Analysis
    100. Key Strategies
    101. PRA Health Sciences
    102. Financial Overview
    103. Products Offered
    104. Key Developments
    105. SWOT Analysis
    106. Key Strategies
    107. Celerion
    108. Financial Overview
    109. Products Offered
    110. Key Developments
    111. SWOT Analysis
    112. Key Strategies
    113. WuXi AppTec
    114. Financial Overview
    115. Products Offered
    116. Key Developments
    117. SWOT Analysis
    118. Key Strategies
    119. Charles River Laboratories
    120. Financial Overview
    121. Products Offered
    122. Key Developments
    123. SWOT Analysis
    124. Key Strategies
    125. Worldwide Clinical Trials
    126. Financial Overview
    127. Products Offered
    128. Key Developments
    129. SWOT Analysis
    130. Key Strategies
    131. Syneos Health
    132. Financial Overview
    133. Products Offered
    134. Key Developments
    135. SWOT Analysis
    136. Key Strategies
    137. PAREXEL International
    138. Financial Overview
    139. Products Offered
    140. Key Developments
    141. SWOT Analysis
    142. Key Strategies
    143. CROMSOURCE
    144. Financial Overview
    145. Products Offered
    146. Key Developments
    147. SWOT Analysis
    148. Key Strategies
    149. ICON plc
    150. Financial Overview
    151. Products Offered
    152. Key Developments
    153. SWOT Analysis
    154. Key Strategies
    155. QuintilesIMS
    156. Financial Overview
    157. Products Offered
    158. Key Developments
    159. SWOT Analysis
    160. Key Strategies
    161. KCR
    162. Financial Overview
    163. Products Offered
    164. Key Developments
    165. SWOT Analysis
    166. Key Strategies
    167. References
    168. Related Reports
    169. South America Clinical Trials Market SIZE ESTIMATES & FORECAST, BY PHASE, 2019-2035 (USD Billions)
    170. South America Clinical Trials Market SIZE ESTIMATES & FORECAST, BY STUDY DESIGN, 2019-2035 (USD Billions)
    171. South America Clinical Trials Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD Billions)
    172. South America Clinical Trials Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    173. South America Clinical Trials Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
    174. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    175. ACQUISITION/PARTNERSHIP
    176. MARKET SYNOPSIS
    177. SOUTH AMERICA CLINICAL TRIALS MARKET ANALYSIS BY PHASE
    178. SOUTH AMERICA CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN
    179. SOUTH AMERICA CLINICAL TRIALS MARKET ANALYSIS BY THERAPEUTIC AREA
    180. SOUTH AMERICA CLINICAL TRIALS MARKET ANALYSIS BY END USE
    181. SOUTH AMERICA CLINICAL TRIALS MARKET ANALYSIS BY REGIONAL
    182. KEY BUYING CRITERIA OF CLINICAL TRIALS MARKET
    183. RESEARCH PROCESS OF MRFR
    184. DRO ANALYSIS OF CLINICAL TRIALS MARKET
    185. DRIVERS IMPACT ANALYSIS: CLINICAL TRIALS MARKET
    186. RESTRAINTS IMPACT ANALYSIS: CLINICAL TRIALS MARKET
    187. SUPPLY / VALUE CHAIN: CLINICAL TRIALS MARKET
    188. CLINICAL TRIALS MARKET, BY PHASE, 2025 (% SHARE)
    189. CLINICAL TRIALS MARKET, BY PHASE, 2019 TO 2035 (USD Billions)
    190. CLINICAL TRIALS MARKET, BY STUDY DESIGN, 2025 (% SHARE)
    191. CLINICAL TRIALS MARKET, BY STUDY DESIGN, 2019 TO 2035 (USD Billions)
    192. CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
    193. CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
    194. CLINICAL TRIALS MARKET, BY END USE, 2025 (% SHARE)
    195. CLINICAL TRIALS MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    196. CLINICAL TRIALS MARKET, BY REGIONAL, 2025 (% SHARE)
    197. CLINICAL TRIALS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
    198. BENCHMARKING OF MAJOR COMPETITORS

    South America Clinical Trials Market Segmentation

     

     

     

    • Clinical Trials Market By Phase (USD Billion, 2019-2035)

      • Phase I
      • Phase II
      • Phase III
      • Phase IV

     

    • Clinical Trials Market By Study Design (USD Billion, 2019-2035)

      • Interventional
      • Observational
      • Expanded Access

     

    • Clinical Trials Market By Therapeutic Area (USD Billion, 2019-2035)

      • Oncology
      • Cardiology
      • Neurology
      • Infectious Diseases
      • Endocrinology

     

    • Clinical Trials Market By End Use (USD Billion, 2019-2035)

      • Pharmaceutical Companies
      • Biotechnology Companies
      • Contract Research Organizations

     

    • Clinical Trials Market By Regional (USD Billion, 2019-2035)

      • Brazil
      • Mexico
      • Argentina
      • Rest of South America

     

    Clinical Trials Market Regional Outlook (USD Billion, 2019-2035)

     

     

    • South America Outlook (USD Billion, 2019-2035)

      • South America Clinical Trials Market by Phase Type

        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • South America Clinical Trials Market by Study Design Type

        • Interventional
        • Observational
        • Expanded Access
      • South America Clinical Trials Market by Therapeutic Area Type

        • Oncology
        • Cardiology
        • Neurology
        • Infectious Diseases
        • Endocrinology
      • South America Clinical Trials Market by End Use Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • South America Clinical Trials Market by Regional Type

        • Brazil
        • Mexico
        • Argentina
        • Rest of South America
      • BRAZIL Outlook (USD Billion, 2019-2035)
      • BRAZIL Clinical Trials Market by Phase Type

        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • BRAZIL Clinical Trials Market by Study Design Type

        • Interventional
        • Observational
        • Expanded Access
      • BRAZIL Clinical Trials Market by Therapeutic Area Type

        • Oncology
        • Cardiology
        • Neurology
        • Infectious Diseases
        • Endocrinology
      • BRAZIL Clinical Trials Market by End Use Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • MEXICO Outlook (USD Billion, 2019-2035)
      • MEXICO Clinical Trials Market by Phase Type

        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • MEXICO Clinical Trials Market by Study Design Type

        • Interventional
        • Observational
        • Expanded Access
      • MEXICO Clinical Trials Market by Therapeutic Area Type

        • Oncology
        • Cardiology
        • Neurology
        • Infectious Diseases
        • Endocrinology
      • MEXICO Clinical Trials Market by End Use Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • ARGENTINA Outlook (USD Billion, 2019-2035)
      • ARGENTINA Clinical Trials Market by Phase Type

        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • ARGENTINA Clinical Trials Market by Study Design Type

        • Interventional
        • Observational
        • Expanded Access
      • ARGENTINA Clinical Trials Market by Therapeutic Area Type

        • Oncology
        • Cardiology
        • Neurology
        • Infectious Diseases
        • Endocrinology
      • ARGENTINA Clinical Trials Market by End Use Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
      • REST OF SOUTH AMERICA Clinical Trials Market by Phase Type

        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • REST OF SOUTH AMERICA Clinical Trials Market by Study Design Type

        • Interventional
        • Observational
        • Expanded Access
      • REST OF SOUTH AMERICA Clinical Trials Market by Therapeutic Area Type

        • Oncology
        • Cardiology
        • Neurology
        • Infectious Diseases
        • Endocrinology
      • REST OF SOUTH AMERICA Clinical Trials Market by End Use Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials